|Values are valid only on day of printing.|
Diagnostic hematopathology has become an increasingly complex subspecialty, particularly with neoplastic disorders of blood and bone marrow. While morphologic assessment of blood smears, bone marrow smears, and tissue sections remains the cornerstone of lymphoma and leukemia diagnosis and classification, immunophenotyping is a very valuable and important complementary tool.
Immunophenotyping hematopoietic specimens can help resolve many differential diagnostic problems posed by the clinical or morphologic features.
This test is appropriate for hematopoietic specimens only. If your specimen is a solid tissue, order LLPT / Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue.
Evaluating lymphocytoses of undetermined etiology
Identifying B- and T-cell lymphoproliferative disorders involving blood and bone marrow
Distinguishing acute lymphoblastic leukemia (ALL) from acute myeloid leukemia (AML)
Immunologic subtyping of ALL
Distinguishing reactive lymphocytes and lymphoid hyperplasia from malignant lymphoma
Distinguishing between malignant lymphoma and acute leukemia
Phenotypic subclassification of B- and T-cell chronic lymphoproliferative disorders, including chronic lymphocytic leukemia, mantle cell lymphoma, and hairy cell leukemia
Recognizing AML with minimal morphologic or cytochemical evidence of differentiation
Recognizing monoclonal plasma cells
Report will include a morphologic description, a summary of the procedure, the percent positivity of selected antigens, and an interpretive conclusion based on the correlation of the clinical history with the morphologic features and immunophenotypic results.
Specimens will be initially triaged to determine which, if any, of the immunophenotyping panels should be performed.
An interpretive report will be provided.
This test will be processed as a laboratory consultation. An interpretation of the immunophenotypic findings and correlation with the morphologic features will be provided by a hematopathologist for every case.
1. Hanson CA, Kurtin PJ, Katzman JA, et al: Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood 1999;94:3889-3896
2. Hanson CA: Acute leukemias and myelodysplastic syndromes. In Clinical Laboratory Medicine. Edited by KD McClatchey. Baltimore, MD, Williams and Wilkins, 1994, pp 939-969
3. Morice WG, Leibson PJ, Tefferi A: Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis. Leuk Lymphoma 2001;41(3-4):277-284
4. Langerak, van Den Beemd, Wolvers-Tettero, et al: Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCR alpha beta T-cell proliferations. Blood 2001;98(1):165-173
5. Hoffman RA, Kung PC, Hansen QP, Goldstein G: Simple and rapid measurement of T lymphocytes and their subclass in peripheral blood. Proc Natl Acad Sci USA 1980;77:4914-4917
6. Jaffe ES, Cossman J: Immunodiagnosis of lymphoid and mononuclear phagocytic neoplasms. In Manual of Clinical Immunology. Third edition. Edited by NR Rose, H Friedman, JL Fahey. ASM Press. 1987, pp 779-790
7. Morice WG, Kimlinger T, Katzmann JA, et al: Flow cytometric assessment of TCR-V-beta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques. Am J Clin Pathol 2004;121(3):373-383
8. Stelzer GT, Shultz KE, Loken MR: CD45 gating for routine flow cytometric analysis of bone marrow specimens. Ann NY Acad Sci 1993;677:265-280